AI assistant
Sending…
Emergent BioSolutions Inc. — Director's Dealing 2012
Dec 28, 2012
32870_dirs_2012-12-28_4eb49496-d594-4559-b11f-0d34416e5bca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2012-12-27
Reporting Person: Abdun-Nabi Daniel (Director, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-27 | Common Stock | M | 7300 | $10.13 | Acquired | 66825 | Direct |
| 2012-12-27 | Common Stock | F | 4677 | $15.81 | Disposed | 62148 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-27 | Employee Stock Option (right to buy) | $10.13 | M | 7300 | Disposed | 2013-12-12 | Common Stock (7300) | Direct |
Footnotes
F1: The option is fully vested.
More from Emergent BioSolutions Inc.
Earnings Release
2026
Apr 30
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Mar 3